Additional Information
Market: AIM
Sector: Pharmaceuticals & Biotechnology
EPIC: PIM
Latest Price: 0.00p  (-1.82% Descending)
52-week High: 35.25p
52-week Low: 13.50p
1 year chart
1 day chart
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
Plant Impact
www.plantimpact.com

Plant Impact's range of crop nutrition products focus on crop enhancement. They improve crop performance and crop health giving growers increased marketable yields, better quality and longer shelf life with reduced environmental impact.

Pdf

Plant impact signs Canada distribution deal

8th Jun 2011, 8:31 am by Jon Mainwaring INCA is a calcium delivery system that enables plants to absorb and retain calcium in tissues where it is most needed

Plant Impact (LON:PIM) has signed a distribution agreement with Canada’s Engage Agro Corporation, which the crop health firm’s management believes will lead to the development of several new technologies for the Canadian market.

The deal grants Engage – which has already worked with INCA for more than two years – the right to market and sell Plant Impact’s INCA crop enhancement technology in Canada on an exclusive basis for an initial period of five years. The agreement contains customary price and sales targets that, if not met, enable Plant Impact to terminate the deal.

"Engage is a well run, respected national distributor for several international companies, now including Plant Impact, and we believe that there is a need in this market for our crop enhancement technologies,” said Pete Blezard, Plant Impact’s CEO.

INCA, the firm’s biggest selling product last year, is a calcium delivery system that enables plants to absorb and retain calcium in tissues where it is most needed.

The latest deal follows May’s news that Japanese agrochemical company Arysta LifeScience had agreed to pay a premium of more than 76 percent to acquire 4.6 million shares in Plant Impact. The firm’s shares shot up by more than 40 percent to trade higher than 36 pence each on 26 May, the day the Arysta deal was announced.

In early trading today, Plant Impact’s share price was up a penny at 28 pence.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.